The prostate is a walnut-sized gland that sits just below the bladder and wraps around the urethra, and its primary job is producing a specialized fluid that keeps sperm alive and mobile after ejaculation. But reducing it to a single function sells it short. The prostate also contracts rhythmically during ejaculation to propel semen outward, serves as a critical waypoint for the nerves that control erections and urinary continence, and acts as a hormone-responsive organ whose behavior changes significantly over a man’s lifetime. Understanding what the prostate actually does, rather than just knowing it as a source of medical problems, helps make sense of why those problems arise and what treatments involve.
The Fluid Factory
Semen is not a single substance. It is a blend of fluids contributed by the testes, the epididymis, the seminal vesicles, and the prostate. The prostate’s contribution makes up roughly a quarter to a third of total semen volume, and this prostatic fluid is loaded with components that sperm need to function once they leave the body. Among the most important are zinc ions, citrate, and a family of enzymes called kallikreins, all of which help orchestrate the cascade of events that follows ejaculation.1Nature Reviews Urology. The role of the prostate in male fertility, health and disease
Citrate production is one of the prostate’s more unusual metabolic feats. Prostate epithelial cells channel glucose into producing and secreting large quantities of citrate rather than burning it fully for energy the way most cells do.2PubMed Central. Carbon sources and pathways for citrate secreted by human prostate cancer cells determined by NMR tracing and metabolic modeling That citrate feeds sperm energetically and helps maintain the slightly acidic-to-neutral pH environment semen needs.
Zinc plays a more intricate role. The prostate concentrates zinc at levels far higher than almost any other tissue in the body. That zinc interacts with proteins from the seminal vesicles called semenogelins, and together they temporarily immobilize sperm right at the moment of ejaculation. This sounds counterproductive, but it serves a purpose: sperm are initially trapped in a gel-like coagulum, which protects them during the earliest moments outside the body.3Molecular Human Reproduction. Physiological roles of semenogelin I and zinc in sperm motility and semen coagulation on ejaculation in humans
From Coagulum to Motile Sperm
The gel that traps sperm does not last long. Within minutes, prostate-specific antigen, better known as PSA, goes to work. PSA is a protease enzyme produced almost exclusively by prostate cells, and its biological job has nothing to do with blood tests or cancer screening. In semen, PSA digests the semenogelin proteins, breaking down the coagulum and gradually releasing sperm so they can start swimming.4PubMed Central. Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen Zinc initially inhibits PSA’s enzyme activity, which is what keeps the gel intact at first. As zinc is gradually sequestered by the semenogelins, PSA becomes active and liquefaction begins. It is an elegantly timed molecular relay.
The fact that PSA is best known as a cancer screening marker obscures its actual function. Both normal prostate cells and cancerous ones produce PSA, and cancer cells maintain the enzymatic machinery to keep it active.5Wiley Online Library (Prostate). Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer? A rising PSA level in the blood does not mean the prostate is making more of the enzyme on purpose for the bloodstream; it means the barrier between the gland’s interior and the circulation has been disrupted by inflammation, enlargement, or tumor growth. PSA “leaks” into the blood rather than being directed there.
How Ejaculation Actually Works
The prostate is not just a passive secretory organ. It is a muscular one. Smooth muscle fibers woven through the prostate’s connective tissue contract during ejaculation, squeezing prostatic secretions into the urethra at precisely timed intervals. Electrophysiology studies have recorded these contractions directly: at rest, the prostate generates baseline electrical waves that maintain low-level tone. During ejaculation, those waves spike in amplitude and frequency, producing intermittent contractions that coincide with each ejaculatory spurt.6PubMed. Contractile activity of the prostate at ejaculation: an electrophysiologic study
These contractions are driven by the sympathetic nervous system, specifically by noradrenergic nerve fibers that densely innervate the smooth muscle stroma of the gland. When those nerves fire, they release noradrenaline, which activates alpha-1 adrenoceptors on the muscle cells and triggers contraction.7PubMed. The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies This is also why alpha-blocker medications, originally designed for blood pressure, are effective at relieving urinary symptoms from an enlarged prostate. They relax the same smooth muscle that otherwise squeezes the urethra closed.
The Nerve Highway Running Through It
One of the prostate’s most consequential roles in male health is not something it does itself but something it hosts. The neurovascular bundles, the paired clusters of nerves and blood vessels that control erections, run along the back and sides of the prostate on their way from the pelvic plexus down to the penis.8PubMed. Neuroanatomy of penile erection: its relevance to iatrogenic impotence Detailed anatomical mapping confirms that the majority of nerve fibers cluster along the dorsal and peripheral edges of the gland, while blood vessels concentrate along the midline.9PubMed. Distribution of neurovascular structures within the prostate gland and their relationship to complications after radical prostatectomy
This anatomy is why prostate surgery carries risks to sexual function and continence that seem out of proportion to removing a walnut-sized organ. The nerves responsible for erections are not inside the prostate; they are draped over it. Any procedure that removes or damages the gland risks injuring these bundles. It also explains why “nerve-sparing” surgery is a central concern of prostate cancer treatment. Surgeons try to peel the gland away from these bundles, but the margin is sometimes a fraction of a centimeter.
What Happens When the Prostate Is Removed
Radical prostatectomy reveals by subtraction just how central the gland is. After removal, all men lose the ability to ejaculate because the organ that produced and propelled the fluid is gone.10PubMed Central. Sexual dysfunction after radical prostatectomy Orgasm is still possible, but many men describe a change in its quality and intensity. Erectile dysfunction is nearly universal immediately after surgery, and recovery is slow, often taking a year or more even when the nerves are spared.
A prospective trial comparing robotic and open prostatectomy found that about one in five men remained incontinent at 12 months, and roughly seven in ten experienced erectile dysfunction, regardless of the surgical approach.11PubMed. Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial Incontinence and erectile dysfunction also appear to be linked after surgery: men with ED are roughly twice as likely to have ongoing incontinence, probably because both depend on the integrity of the same neurovascular anatomy.12The Journal of Sexual Medicine. The Relationship Between Incontinence and Erectile Dysfunction After Robotic Prostatectomy: Are They Mutually Exclusive?
Hormones and the Growing Prostate
The prostate is one of the most androgen-sensitive organs in the body. Its growth, maintenance, and secretory function all depend on a working androgen signaling chain: testosterone is produced in the testes, converted inside the prostate to a more potent form called dihydrotestosterone (DHT) by an enzyme called 5-alpha reductase, and DHT then binds to androgen receptors in prostate cells to regulate gene activity.13PubMed. The role of dihydrotestosterone in benign prostatic hyperplasia Without androgens, the prostate does not develop in the first place. In adult men, androgens keep it functioning normally, driving both the production of prostatic fluid and the survival of the cells that make it.14PubMed Central. Androgen action in prostate function and disease
The problem is that the same hormonal machinery that builds and sustains the prostate can also drive pathological growth. In benign prostatic hyperplasia, DHT promotes proliferation in the transitional zone of the gland, the ring of tissue immediately surrounding the urethra.15PubMed Central. The Etiology and Pathogenesis of Benign Prostatic Hyperplasia: The Roles of Sex Hormones and Anatomy Because the urethra passes straight through this zone, even modest enlargement can squeeze the urinary channel and produce the familiar symptoms: weak stream, frequent urination, nighttime waking. Drugs that block 5-alpha reductase can shrink the prostate by cutting off its DHT supply, which is the only class of medication that targets the underlying growth process rather than just relaxing the muscle.16PubMed Central. The role of 5-alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?
Why BPH and Cancer Arise in Different Places
The prostate is not a uniform ball of tissue. It has distinct anatomical zones, and different diseases favor different zones. BPH almost exclusively develops in the transitional zone near the urethra, which is why it affects urination early on. Prostate cancer, by contrast, overwhelmingly arises in the peripheral zone, the outermost layer of glandular tissue that sits closest to the rectum. A systematic review covering more than 12,700 specimens found that about 73% of prostate cancers originated in the peripheral zone.17Exploratory Research and Hypothesis in Medicine. The Origin of BPH and Prostate Cancer in Different Prostate Zones and the Impact on the Incidence of Prostate Cancer Smaller peripheral-zone tumors tend to stay confined to their zone of origin, only spreading across zones once they reach larger volumes.18PubMed. Peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology
This zonal split has practical consequences. Because the peripheral zone is the outermost layer, tumors there are often palpable during a digital rectal exam even when they are still small. It also explains why having BPH does not, in itself, mean you are developing cancer. The two conditions grow from different tissue compartments with different cellular environments, even though they share the same gland. The transitional zone has its own distinct immune and stromal signaling, including different responses from infiltrating immune cells, that drive stromal expansion during BPH.19PubMed Central. The androgen receptor plays different roles in macrophage-induced proliferation in prostate stromal cells between transitional and peripheral zones of benign prostatic hypertrophy
Prostatitis and the Problem of Pain Without a Clear Cause
Not all prostate trouble involves growth or cancer. Prostatitis, or inflammation of the prostate, is one of the most common urological diagnoses in younger and middle-aged men. Acute and chronic bacterial prostatitis, caused by identifiable infections, respond reasonably well to antibiotics. But they account for only a small fraction of cases. The vast majority, around 90 to 95%, fall under the category of chronic prostatitis or chronic pelvic pain syndrome, a condition with no identifiable infection and no uniformly effective treatment.20PubMed. Prostatitis/chronic pelvic pain syndrome
Symptoms can include pain in the pelvis, perineum, or genitals, urinary difficulties, and sexual dysfunction. These patients are typically managed according to whichever symptom pattern predominates, because the underlying cause remains unclear and no single therapy works for everyone.21PubMed Central. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline Even when bacterial prostatitis is identified, treating it can be difficult because the prostate has its own internal barrier, sometimes called the blood-prostate barrier, that limits how much of an antibiotic actually reaches the gland’s interior. Only drugs with the right combination of fat solubility, molecular charge, and low protein binding cross this barrier effectively.22PubMed Central. Antibiotic Pharmacokinetics and Prostate Penetration in Bacterial Prostatitis: A Systematic Review
The Blood-Prostate Barrier
The blood-prostate barrier deserves attention beyond the context of infections, because it shapes how the prostate interacts with the rest of the body. This barrier sits between the gland’s blood supply and the interior of the prostatic ducts, and it is made up of capillary walls, a basement membrane, stromal tissue, and the epithelial lining of the ducts themselves. It dynamically controls which molecules pass between the bloodstream and the gland’s lumen.23PubMed. The Blood-prostate Barrier: An Obstacle to Drug Delivery into the Prostate This barrier is why PSA normally stays mostly inside the gland and why treating prostate infections is harder than treating, say, a skin infection. It is also a major research focus for drug delivery, since getting cancer drugs or antibiotics past it efficiently could improve outcomes for several prostate conditions.
Metabolic Health and the Prostate
The prostate does not exist in hormonal isolation. Growing evidence links metabolic syndrome, a cluster of conditions including abdominal obesity, insulin resistance, high blood pressure, and abnormal cholesterol, to both prostate enlargement and worsening urinary symptoms. The pathways connecting metabolic health to prostate growth are still being worked out, but insulin resistance, changes in sex hormone levels, increased visceral fat, and chronic low-grade inflammation all appear to play a role.24PubMed Central. Metabolic syndrome and benign prostatic hyperplasia: An update
In a retrospective cohort study, measures of abdominal obesity, including waist circumference, body fat percentage, and visceral fat composition, all correlated with having a prostate volume above 40 milliliters, which is the threshold often used to define significant enlargement. Men in the highest quartile of serum leptin, a hormone produced by fat cells, were about three and a half times more likely to have high-volume BPH than those in the lowest quartile.25PubMed Central. Obesity as a Risk Factor for Prostatic Enlargement: A Retrospective Cohort Study in Korea The practical takeaway is that managing weight and metabolic health may have benefits for the prostate that go beyond general fitness advice.
Aging and Cellular Senescence
The prostate changes with age in ways that go beyond simple enlargement. At the cellular level, aging prostate tissue accumulates senescent cells, cells that have stopped dividing but remain metabolically active and secrete a cocktail of inflammatory signals. This senescence-associated secretory phenotype creates an inflamed local environment that promotes immune cell infiltration and, paradoxically, stimulates neighboring cells to proliferate, contributing to the nodular growth pattern characteristic of BPH.26PubMed Central. Stimulation of Prostate Cells by the Senescence Phenotype of Epithelial and Stromal Cells: Implication for Benign Prostate Hyperplasia
Mouse studies comparing young and aged prostate tissue have found that the gene expression changes in aging stroma do not neatly match the classic markers of cellular senescence seen in lab dishes. Some expected inflammatory signals were not elevated in aged prostates, while other molecules were.27PLoS ONE. The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment The picture is that aging in the prostate is not just “cells getting old” in the way the public tends to imagine it. It involves complex shifts in the tissue microenvironment, including changes in immune surveillance and stromal signaling, that set the stage for disease long before symptoms appear.
Modern Imaging and How Prostate Assessment Has Changed
For decades, prostate evaluation relied heavily on PSA blood tests and digital rectal exams. Both remain useful but imperfect. Multiparametric MRI has significantly improved the detection of clinically significant prostate cancer while reducing overdiagnosis of low-risk tumors. Compared with conventional systematic biopsy, MRI-guided approaches detect meaningful cancers with higher sensitivity, about 72% versus 63%, while flagging fewer slow-growing cancers that would never have caused harm.28PubMed Central. Imaging of Prostate Cancer PSMA-based PET/CT scans, which target a protein found on prostate cancer cells, have become the standard for detecting cancer spread in high-risk patients and for tracking recurrence after treatment.
Even with these advances, the digital rectal exam has not been entirely replaced. A recent study found that suspicious findings on rectal exam correlated with higher uptake on PSMA PET scans, suggesting the physical exam still adds information, particularly in settings where advanced imaging is not immediately available.29PubMed Central. In the Era of mpMRI and PSMA PET/CT: Does Digital Rectal Examination Still Matter?
An Evolutionary Perspective
The prostate is not unique to humans. All male mammals have one, and it appeared roughly 65 million years ago alongside the rise of the mammalian lineage.30PubMed. Similarities of prostate and breast cancer: Evolution, diet, and estrogens Comparative studies across mammalian species have found that prostate size, corrected for body weight, correlates with relative testes size. Species where females mate with multiple males, creating intense sperm competition, tend to have larger prostates and larger seminal vesicles. This pattern holds even after correcting for evolutionary relatedness among species, strongly suggesting that sexual selection has been a driving force in shaping the gland’s size and secretory output.31Current Zoology. Sexual selection affects the sizes of the mammalian prostate gland and seminal vesicles
In other words, the prostate is not an incidental structure that happens to cause trouble in aging men. It was shaped by millions of years of selection pressure to maximize reproductive success, which helps explain why it is so hormonally responsive, so metabolically active, and so deeply integrated into the reproductive and urinary tracts. The same features that made it reproductively effective, dense vascularity, high growth factor production, exquisite hormone sensitivity, are the features that make it vulnerable to disease later in life. Evolution optimized it for reproduction in young adulthood, not for quiet retirement at seventy.